Keyphrases
Sinus
96%
Inflammation
96%
Systemic Disease
96%
IgG4-related Disease (IgG4-RD)
48%
Sarcoidosis
48%
Vasculitis
48%
Avacopan
48%
Real-world Experience
48%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
48%
Granulomatosis with Polyangiitis
48%
Sinonasal
19%
Chronic Rhinosinusitis
17%
Tissue Biopsy
14%
Clinical Features
14%
ANCA-associated Vasculitis
12%
Estimated Glomerular Filtration Rate
12%
Clinical Remission
12%
Postmarketing
12%
Rituximab
11%
Sinus Surgery
8%
Diagnostic Criteria
8%
Sinonasal Disease
8%
Otolaryngology
8%
Review Process
8%
Diagnostic Management
8%
Immunosuppressive Agents
8%
Diagnostic Work-up
8%
Multisystem Disease
8%
Predictors of Remission
6%
Descriptive Statistics
6%
Remission
6%
Serum Aminotransferases
6%
Retrospective Analysis
6%
Median Time
6%
Prednisone
6%
Univariate Logistic Regression
6%
Acceptable Safety
6%
Kidney Involvement
6%
Adverse Events
6%
Combination Therapy
6%
Low-dose Cyclophosphamide
6%
Newly Diagnosed
6%
Kidney Replacement Therapy
6%
Safety Profile
6%
Plasma Exchange
6%
Debulking
5%
Symptom Relief
5%
Resection
5%
Autoimmune
5%
Inflammatory Conditions
5%
Medicine and Dentistry
Vasculitis
100%
Systemic Disease
96%
Sarcoidosis
48%
Avacopan
48%
Granulomatosis with Polyangiitis
48%
Autoantibodies
48%
Hand-Schüller-Christian Disease
48%
IgG4-Related Disease
48%
Diseases
28%
Biopsy Technique
19%
Chronic Rhinosinusitis
17%
Clinical Feature
14%
ANCA Associated Vasculitis
12%
Glomerular Filtration Rate
12%
Rituximab
11%
Sinus Surgery
8%
Otorhinolaryngology
8%
Immunosuppressive Drug
8%
Diagnosis
8%
Low Drug Dose
6%
Combination Therapy
6%
Plasma Exchange
6%
Adverse Event
6%
Logistic Regression Analysis
6%
Renal Replacement Therapy
6%
Transaminase
6%
Prednisone
6%
Cyclophosphamide
6%
Debulking
5%
Delayed Diagnosis
5%
Serositis
5%
Surgery
5%